Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial.
Jain MK, De Lemos JA, McGuire DK, Ayers C, Eitson JL, Sanchez CL, Kamel D, Meisner JA, Thomas EV, Hegde AA, Mocherla S, Strebe JK, Li X, Williams NS, Xing C, Ahmed MS, Wang P, Sadek HA, Schoggins JW.
Jain MK, et al. Among authors: hegde aa.
Front Pharmacol. 2022 Sep 30;13:1020123. doi: 10.3389/fphar.2022.1020123. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36249792
Free PMC article.